K. E. Britton

A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG).

J. Bomanji, K. Solanki, K. Britton, 1992, Nuclear medicine communications.

Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.

J. Fettich, A. Al-nahhas, J. Bomanji, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'.

M. Kamm, J. Lennard-jones, S. Mather, 1993, Gut.

Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers.

K E Britton, M. Kamm, J. Lennard-jones, 1993, Gut.

A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.

A. Grossman, S. Mather, J. Bomanji, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study

A. Grossman, S. Mather, A. Signore, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

A radiopharmaceutical for imaging areas of lymphocytic infiltration: 123I-interleukin-2. Labelling procedure and animal studies.

G. Ronga, A. Signore, P. Pozzilli, 1992, Nuclear medicine communications.